Lumosa Therapeutics (Taiwan) Today

6535 Stock  TWD 179.00  1.00  0.56%   

Performance

29 of 100

 
Low
 
High
Strong
Lumosa Therapeutics is selling for under 179.00 as of the 28th of March 2024; that is -0.56% down since the beginning of the trading day. The stock's lowest day price was 177.0. Lumosa Therapeutics has 50 percent odds of going through some form of financial distress in the next two years but had a very strong returns during the last 90 days. Equity ratings for Lumosa Therapeutics Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.

Lumosa Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lumosa Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lumosa Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, General ManagerWenIng Huang
Lumosa Therapeutics Co (6535) is traded on Taiwan OTC Exchange in Taiwan and employs 8 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lumosa Therapeutics's market, we take the total number of its shares issued and multiply it by Lumosa Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Check Lumosa Therapeutics Probability Of Bankruptcy

Lumosa Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Lumosa Therapeutics jumping above the current price in 90 days from now is about 10.18%. The Lumosa Therapeutics Co probability density function shows the probability of Lumosa Therapeutics stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Lumosa Therapeutics has a beta of 0.3145. This suggests as returns on the market go up, Lumosa Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Lumosa Therapeutics Co will be expected to be much smaller as well. Moreover, lumosa Therapeutics Co has an alpha of 1.5582, implying that it can generate a 1.56 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 180.0HorizonTargetOdds Above 180.0
89.79%90 days
 180.00 
10.18%
Based on a normal probability distribution, the odds of Lumosa Therapeutics to move above the current price in 90 days from now is about 10.18 (This Lumosa Therapeutics Co probability density function shows the probability of Lumosa Stock to fall within a particular range of prices over 90 days) .

Lumosa Therapeutics Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lumosa Therapeutics market risk premium is the additional return an investor will receive from holding Lumosa Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lumosa Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lumosa Therapeutics' alpha and beta are two of the key measurements used to evaluate Lumosa Therapeutics' performance over the market, the standard measures of volatility play an important role as well.

Lumosa Therapeutics Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Lumosa Therapeutics Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Lumosa Therapeutics price patterns.

Lumosa Stock Against Markets

Picking the right benchmark for Lumosa Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lumosa Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lumosa Therapeutics is critical whether you are bullish or bearish towards Lumosa Therapeutics Co at a given time. Please also check how Lumosa Therapeutics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lumosa Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

How to buy Lumosa Stock?

Before investing in Lumosa Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lumosa Therapeutics. To buy Lumosa Therapeutics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lumosa Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Lumosa Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Lumosa Therapeutics Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Lumosa Therapeutics Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lumosa Therapeutics Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Lumosa Therapeutics Co?

The danger of trading Lumosa Therapeutics Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lumosa Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lumosa Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lumosa Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lumosa Therapeutics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Lumosa Stock analysis

When running Lumosa Therapeutics' price analysis, check to measure Lumosa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lumosa Therapeutics is operating at the current time. Most of Lumosa Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lumosa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lumosa Therapeutics' price. Additionally, you may evaluate how the addition of Lumosa Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Please note, there is a significant difference between Lumosa Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lumosa Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lumosa Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.